已有11条早期研发管线的CAR-T细胞治疗产品组合、在积极探索已上市产品西达基奥仑赛作为多发性骨髓瘤早期治疗的潜力且有3项临床试验正在开展......这是第43届摩根大通医疗健康年会（JPM）上，传奇生物首席执行官（CEO）黄颖1月15日演讲时透露的 ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Flagship Pioneering Innovations VI LLC has synthesized ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) inhibitors.

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at ...

Linaclotide, a guanylate cyclase C receptor agonist, has shown promising efficacy as a treatment for chronic constipation in a phase IIb, double-blinded, placebo-controlled, dose-ranging trial.

inhaled soluble Guanylate Cyclase (sGC) activator with targeted delivery to the lungs via once-daily administration, which may have broad applicability across the spectrum of pulmonary ...

The most promising candidate target for an alternative therapeutic approach is pituitary adenylate cyclase-activating polypeptide (PACAP). Lu AG09222, a humanised monoclonal intravenous antibody ...

After a quiet few years Merck has returned to the category with soluble guanylate cyclase (sGC) stimulators Adempas (riociguat) and Verquvo (vericiguat) – partnered with Bayer – for PAH and ...

A protein called pituitary adenylate-cyclase activating protein may also play a role. There’s no established link between migraine severity and postdrome occurrence. However, a 2024 study ...